Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;26(6):e14319.
doi: 10.1111/petr.14319. Epub 2022 May 26.

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients

Taito Kitano  1   2 , Aaron Campigotto  3 , Upton Allen  1
Affiliations
Editorial

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients

Taito Kitano et al. Pediatr Transplant. 2022 Sep.
No abstract available

Keywords: Antibody; COVID-19; Immunogenicity; SARS-CoV-2; Solid organ transplant.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest related to this study.

Comment on

References

    1. Feingold B, Berman P, Moninger A, et al. Responsiveness to second and third dose of mRNA COVID‐19 vaccination in adolescent and young adult heart transplant recipients [published online ahead of print, 2022 Mar 27]. Pediatr Transplant. 2022;e14272. doi:10.1111/petr.14272 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Interim clinical considerations for use of COVID‐19 vaccines currently approved or authorized in the United States. https://www.cdc.gov/vaccines/covid‐19/clinical‐considerations/covid‐19‐v.... Accessed on Mar 8, 2022.
    1. Muruato AE, Fontes‐Garfias CR, Ren P, et al. A high‐throughput neutralizing antibody assay for COVID‐19 diagnosis and vaccine evaluation [published correction appears in Nat Commun. 2021 Jun 22;12(1):4000]. Nat Commun. 2020;11(1):4059 Published 2020 Aug 13. doi:10.1038/s41467-020-17892-0 - DOI - PMC - PubMed
    1. Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS‐CoV‐2 infection. Nat Med. 2021;27(7):1205‐1211. doi:10.1038/s41591-021-01377-8 - DOI - PubMed
    1. Earle KA, Ambrosino DM, Fiore‐Gartland A, et al. Evidence for antibody as a protective correlate for COVID‐19 vaccines. Vaccine. 2021;39(32):4423‐4428. doi:10.1016/j.vaccine.2021.05.063 - DOI - PMC - PubMed